Pubblicazioni

Cost-effectiveness analysis of Tapentadol versus Oxycodone/Naloxone in both branded and generic formulations in patients with musculoskeletal pain

2021 - CLINICAL DRUG INVESTIGATION

Ruggeri, Matteo; Signorini, Alessandro; Caravaggio, Silvia; Santori, Costanza; Rosiello, Francesco; Coluzzi, Flaminia

Preliminary cost-effectiveness analysis of the measures put in the place by EU member states to implement the directive on reduction of sulphur content in fuels used by ships

2020 - Maritime Transport 2019

Rotoli, Francesco; Calcagno, Guido; Alda, Sergio; Horrillo, MERCEDES GARCIA; Ricci, Stefano; Rizzetto, Luca

Cost-effectiveness of direct acting oral anticoagulants in the prevention of thromboembolic complications. Limits and concerns of economic evaluations

2019 - JOURNAL OF CARDIOVASCULAR MEDICINE

Russo, P.; Rosano, G. M. C.; Favato, G.; Staniscia, T.; Romano, F.

Cost-effectiveness analysis of early treatment of chronic HCV with sofosbuvir/velpatasvir in Italy

2018 - APPLIED HEALTH ECONOMICS AND HEALTH POLICY

Ruggeri, M.; Romano, F.; Basile, M.; Coretti, S.; Rolli, F. R.; Drago, C.; Cicchetti, A

Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy

2017 - HAEMOPHILIA

Coppola, A.; D'Ausilio, Alessandro; Aiello, A.; Amoresano, S.; Toumi, M.; Mathew, P.; Tagliaferri, A; Feola, G.; Molinari, A. C.; Santoro, Cristina; Rivolta, G. F.; Cultrera, D. B.; Gagliano, F.; Zanon, E.; Mancuso, M. E.; ValdrÃ¨, L.; Mameli, L.; Banov, L.; Di Minno, G.; Quintavalle, G.; Mazzucconi, Maria Gabriella; Negri, N.; Santagostino, E.

Cost-effectiveness analysis of universal human papillomavirus vaccination using a dynamic bayesian methodology. The BEST II study

2015 - VALUE IN HEALTH

Haeussler, Katrin; Marcellusi, Andrea; Mennini, Francesco Saverio; Favato, Giampiero; Picardo, Mauro; Garganese, Giorgia; Bononi, Marco; Costa, Silvano; Scambia, Giovanni; Zweifel, Peter; Capone, Alessandro; Baio, Gianluca